p-Index From 2021 - 2026
0.444
P-Index
This Author published in this journals
All Journal Universa Medicina
Md Nadeem Bari
Department of Basic Medical Sciences, College of Medicine, Prince Sattam bin Abdulaziz University, Al-Kharj, 11942, Saudi Arabia

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Gamma-oryzanol as a potential intervention for normalizing insulin secretion and pancreatic β-cell function Mamoun Abdelwahab Mohammed Elamin Alfaki; Md Nadeem Bari; Md Rizwan Ansari; Imran Mohammad; Mohammad Anwar
Universa Medicina Vol. 45 No. 2 (2026): Ahead Of Print
Publisher : Faculty of Medicine, Universitas Trisakti

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.18051/UnivMed.2026.v45.%p

Abstract

The bioactive substance gamma-oryzanol (GO), which is mostly present in rice bran oil, has attracted a lot of interest due to its possible therapeutic application in metabolic conditions like diabetes mellitus. The effects of GO on insulin secretion and pancreatic β-cell function are examined in this study. Gamma-oryzanol improves β-cell viability, lowers oxidative stress, and modifies intracellular signaling pathways linked to glucose metabolism, all of which increase insulin secretion, according to experimental and clinical evidence. Additionally, GO's anti-inflammatory and antioxidant qualities shield β-cells from dysfunction and apoptosis brought on by hyperglycemia and lipid toxicity. Relevant studies were identified through a systematic search of PubMed, ScienceDirect, and Google Scholar for articles published between 2017 and 2026 using the keyword “gamma-oryzanol”, “insulin secretion”, ‘pancreatic β-cell function”. Additionally, the substance seems to support glucose homeostasis and pancreatic function by upregulating important genes involved in insulin synthesis and secretion. All things considered, GO shows great promise as a natural agent for maintaining β-cell integrity and increasing insulin secretion, providing a novel complementary approach to managing diabetes. Gamma-oryzanol is frequently linked to anti-inflammatory, anti-cancer, anti-diabetic, and cholesterol-lowering properties. Because Orz reduces insulin activity, cholesterol metabolism, and associated chronic inflammation, its potential to treat metabolic diseases has recently been investigated. After apoptosis and increased endoplasmic reticulum (ER) stress were decreased, oral GO administration increased glucose-stimulated insulin secretion in islets from diabetic mice fed a high-fat diet. We also examined the effects of GO on low-dose streptozotocin-induced diabetic mice, which demonstrated elevated ER stress and consequent β-cell apoptosis. Furthermore, γ-oryzanol improved glucose dysmetabolism in this model by lowering the mRNA levels of genes linked to apoptotic signaling and ER stress in islets. All things considered, GO shows encouraging potential as a natural agent for enhancing insulin secretion and maintaining the integrity of β-cells, providing a new complementary strategy for controlling and preventing diabetes.
Type 2 diabetes mellitus and recent treatment options in adolescents and young adults Md Nadeem Bari; Md Rizwan Ansari; Mohammad Anwar; Imran Mohammad
Universa Medicina Vol. 44 No. 3 (2025)
Publisher : Faculty of Medicine, Universitas Trisakti

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.18051/UnivMed.2025.v44.394-405

Abstract

Although type 2 diabetes mellitus (T2DM) has historically been thought of as a disease that mostly affects adults, its incidence among adolescents and young people has been rising in tandem with the rising rates of childhood obesity. There is no evidence to support the best course of treatment for T2DM in this age group despite the undeniable benefits of lifestyle adjustment for obese kids. Early diabetes start is linked to extended exposure to the disease and a greater likelihood of chronic issues, which impact more individuals during their working years and highlight the negative social effects of the condition. Additionally, there is mounting evidence that juvenile diabetes cohorts exhibit an aggressive phenotype that contributes to the early onset of problems that negatively affect life quality and negatively impact long-term results, increasing the possibility of a future public health emergency. Relevant studies were identified through a systematic search of PubMed, ScienceDirect, and Google Scholar for articles published between 2019 and 2025 using the keyword “Adolescents and (T2DM or Insulin Resistance)”. Type 2 diabetes in young people is a serious global public health issue now. Many significant obstacles must be overcome to treat T2DM that develops in young people, including a lack of effective treatment alternatives and limitations in carrying out therapeutic research. The US Food and Drug Administration has approved metformin, glimepiride (Amaryl), and insulin as treatments for teenagers and young adults with type 2 diabetes, despite therapeutic medication studies. Given modified pharmaceutical laws, it is probable that further anti-diabetic drugs will be included in the arsenal of treatment choices available to teenagers and young adults with T2DM. The epidemiology and current understanding of the pathophysiology, risk factors, consequences, and therapy of T2DM in adolescents and young adults are discussed in this review.